Skip to main content

Table 3 Comparison of the new and old biopsy schemes

From: A prostate biopsy strategy based on a new clinical nomogram reduces the number of biopsy cores required in high-risk patients

 

Second stage

First stage

P

 

n(%)

n(%)

 

Total

   

N

238

1104

 

Age

69.7 ± 7.3

68.8 ± 7.9

0.116

Biopsy cores

10.5 ± 2.8

13

<0.001

Positive rate

85(35.7)

458(41.5)

0.109

Subjects with PCP > 0.5

  

N

78

384

 

Age

72.2 ± 6.8

71.7 ± 6.9

0.51

Biopsy cores

6.9 ± 2.1

13

<0.001

Positive rate

55(70.5)

302(78.6)

0.138

Back to article page

BMC Urology

ISSN: 1471-2490

Contact us